by Charice Kalis | Jul 18, 2023 | Press Release
NanoHive Medical has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its 22mm length Hive™ PL Interbody System. The 22mm length implants are a line extension to the current Hive PLIF interbody devices and feature a 9mm width and variety...
by Charice Kalis | Apr 11, 2023 | Press Release
NanoHive Medical announced today the award of a Federal Supply Schedule Contract by the US Department of Veteran Affairs (VA). The contract grants access to the Veteran’s Health Administration (VHA) for the company’s complete line of 3D printed Hive™ interbody devices...
by Charice Kalis | Jan 9, 2023 | Press Release
NanoHive Medical has received 510(k) Clearance from the U.S Food and Drug Administration (FDA) for its Hive™ Standalone Cervical System. The implant system features both a zero profile design, interfixated with two self-tapping screws, as well as a cage and plate...
by admin | May 16, 2022 | Press Release
NanoHive Medical today announced the expansion of its patent portfolio with the issuance of patent number US11,253,368 B2, Methods of Designing High X-Ray Lucency Lattice Structures. The patent is the 16th issued patent for NanoHive, and represents a broad piece of...
by admin | Apr 11, 2022 | Press Release
Further expands distribution of NanoHive Medical’s Hive™Soft Titanium®3D printed interbody fusion technology BOSTON, Mass., February 21, 2022 – NanoHive Medical, LLC (previously HD LifeSciences), a leading innovator in 3D printed, biomimetic spinal interbody fusion...
by admin | Mar 15, 2022 | Press Release
NanoHive Medical is excited to announce that the company has been selected to present at the Canaccord Genuity Musculoskeletal Conference, March 22, 2022. Patrick O’Donnell, President & CEO for NanoHive Medical, will be presenting on the company’s Hive™...
